Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
NMPA:10
Drug Approvals
Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Product Name
- 盐酸莫西沙星氯化钠注射液
- Approval Number
- 国药准字H20249077
- Approval Date
- Oct 16, 2024
NMPA
Piperacillin Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用哌拉西林钠他唑巴坦钠
- Approval Number
- 国药准字H20243885
- Approval Date
- Jun 4, 2024
NMPA
Piperacillin Sodium and Tazobactam Sodium for Injection
- Product Name
- 注射用哌拉西林钠他唑巴坦钠
- Approval Number
- 国药准字H20243884
- Approval Date
- Jun 4, 2024
NMPA
Paroxetine Hydrochloride Tablets
- Product Name
- 盐酸帕罗西汀片
- Approval Number
- 国药准字H20243196
- Approval Date
- Feb 20, 2024
NMPA
Clinical Trials
No trials found
News
No news found